G Medical Innovations Holdings Ltd. (GMVD)
$0.03
As on 25-Oct-2023 09:30EDT
Market cap
$2 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
6.1
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-23 Mln
-
ROE
-8.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.2
-
Debt to Equity
--
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
9,815,560
6 Years Aggregate
CFO
$-64.66 Mln
EBITDA
$-107.48 Mln
Net Profit
$-101.26 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
G Medical Innovations Holdings (GMVD)
| -99.0 | -44.5 | -90.7 | -99.5 | -91.4 | -- | -- |
|
BSE Sensex*
| -10.4 | -1.0 | -7.8 | -7.7 | 6.7 | 8.3 | 11.1 |
|
Company
|
2022
|
|---|---|
|
G Medical Innovations Holdings (GMVD)
| -94.4 |
|
BSE Sensex
| 4.4 |
|
BSE Sensex
| 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout G Medical Innovations Holdings (GMVD)
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The... company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel. Read more
-
Pres, CEO, MD & Exec. Director
Dr. Yacov Geva
-
Pres, CEO, MD & Exec. Director
Dr. Yacov Geva
-
Headquarters
Rehovot
-
Website
FAQs for G Medical Innovations Holdings (GMVD)
What is the current share price of G Medical Innovations Holdings Ltd (GMVD) Today?
The share price of G Medical Innovations Holdings Ltd (GMVD) is $0.03 (NASDAQ) as of 25-Oct-2023 09:30 EDT. G Medical Innovations Holdings Ltd (GMVD) has given a return of -91.38% in the last 3 years.
What is the current PB & PE ratio of G Medical Innovations Holdings Ltd (GMVD)?
Since, TTM earnings of G Medical Innovations Holdings Ltd (GMVD) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
What is the 52 Week High and Low of G Medical Innovations Holdings Ltd (GMVD)?
The 52-week high and low of G Medical Innovations Holdings Ltd (GMVD) are Rs -- and Rs -- as of 28-May-2026.
What is the market cap of G Medical Innovations Holdings Ltd (GMVD)?
G Medical Innovations Holdings Ltd (GMVD) has a market capitalisation of $ 2 Mln as on 25-Oct-2023. As per SEBI classification, it is a company.
Should I invest in G Medical Innovations Holdings Ltd (GMVD)?
Before investing in G Medical Innovations Holdings Ltd (GMVD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.